Cargando…

Poly(I:C) enhances mesenchymal stem cell control of myeloid cells from COVID-19 patients

Mesenchymal stem cells (MSCs) are being studied for the treatment of COVID-19-associated critical illness, due to their immunomodulatory properties. Here, we hypothesized that viral mimic-priming improves MSCs’ abilities to rebalance the dysregulated immune responses in COVID-19. Transcriptome analy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Souza-Moreira, Luciana, Tan, Yuan, Wang, Yan, Wang, Jia-Pey, Salkhordeh, Mahmoud, Virgo, Jennifer, Florian, Maria, Murray, Aidan B.P., Watpool, Irene, McIntyre, Lauralyn, English, Shane, Stewart, Duncan J., Mei, Shirley H.J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975597/ https://www.ncbi.nlm.nih.gov/pubmed/35402859 http://dx.doi.org/10.1016/j.isci.2022.104188

Ejemplares similares

Thawed Mesenchymal Stem Cell Product Shows Comparable Immunomodulatory Potency to Cultured Cells In Vitro and in Polymicrobial Septic Animals
por: Tan, Yuan, et al.
Publicado: (2019)

Mesenchymal stem cells induce dynamic immunomodulation of airway and systemic immune cells in vivo but do not improve survival for mice with H1N1 virus-induced acute lung injury
por: Tan, Yuan, et al.
Publicado: (2023)

Effects of Mesenchymal Stem Cell Treatment on Systemic Cytokine Levels in a Phase 1 Dose Escalation Safety Trial of Septic Shock Patients*
por: Schlosser, Kenny, et al.
Publicado: (2019)

Choice of crystalloid fluid in the treatment of hyperglycemic emergencies: a systematic review protocol
por: Gershkovich, Benjamin, et al.
Publicado: (2019)

Lack of elevation in plasma levels of pro-inflammatory cytokines in common rodent models of pulmonary arterial hypertension: questions of construct validity for human patients
por: Schlosser, Kenny, et al.
Publicado: (2017)

Red blood cell transfusion and mortality effect in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis protocol
por: English, Shane W, et al.
Publicado: (2015)

Metabolomics Analysis of Mesenchymal Stem Cell (MSC) Therapy in a Phase I Clinical Trial of Septic Shock: An Exploratory Study
por: Banoei, Mohammad M., et al.
Publicado: (2023)

Comparison of freshly cultured versus cryopreserved mesenchymal stem cells in animal models of inflammation: A pre-clinical systematic review
por: Dave, Chintan, et al.
Publicado: (2022)

Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: An updated systematic review and meta-analysis
por: Thompson, Mary, et al.
Publicado: (2020)

Transfusion of red blood cells in patients with traumatic brain injuries admitted to Canadian trauma health centres: a multicentre cohort study
por: Boutin, Amélie, et al.
Publicado: (2017)

Exploiting poly(I:C) to induce cancer cell apoptosis
por: Bianchi, Francesca, et al.
Publicado: (2017)

The conundrum of persistent inappropriate use of frozen plasma
por: Tinmouth, Alan T, et al.
Publicado: (2011)

High circulating angiopoietin-2 levels exacerbate pulmonary inflammation but not vascular leak or mortality in endotoxin-induced lung injury in mice
por: Schlosser, Kenny, et al.
Publicado: (2018)

Myeloid-derived suppressor cells exacerbate poly(I:C)-induced lung inflammation in mice with renal injury and older mice
por: Xie, Zhiqi, et al.
Publicado: (2023)

Control of Interferon Production in Rabbit Cells Treated with Poly I:C
por: Armstrong, John A.
Publicado: (1970)

Comparison of crystalloid resuscitation fluids for treatment of acute brain injury: a clinical and pre-clinical systematic review and network meta-analysis protocol
por: Thompson, Mary, et al.
Publicado: (2018)

Customized Internal Reference Controls for Improved Assessment of Circulating MicroRNAs in Disease
por: Schlosser, Kenny, et al.
Publicado: (2015)

Gene engineered mesenchymal stem cells: greater transgene expression and efficacy with minicircle vs. plasmid DNA vectors in a mouse model of acute lung injury
por: Florian, Maria, et al.
Publicado: (2021)

Saline versus albumin fluid for extracorporeal removal with slow low-efficiency dialysis (SAFER-SLED): study protocol for a pilot trial
por: Clark, Edward G., et al.
Publicado: (2019)

Safety of Cell Therapy with Mesenchymal Stromal Cells (SafeCell): A Systematic Review and Meta-Analysis of Clinical Trials
por: Lalu, Manoj M., et al.
Publicado: (2012)

Human papillomavirus-exposed Langerhans cells are activated by stabilized Poly-I:C
por: Da Silva, Diane M., et al.
Publicado: (2015)

Combined Adjuvant of Poly I:C Improves Antitumor Effects of CAR-T Cells
por: Di, Shengmeng, et al.
Publicado: (2019)

Poly-IC enhances the effectiveness of cancer immunotherapy by promoting T cell tumor infiltration
por: Sultan, Hussein, et al.
Publicado: (2020)

Evaluating mesenchymal stem cell therapy for sepsis with preclinical meta-analyses prior to initiating a first-in-human trial
por: Lalu, Manoj M, et al.
Publicado: (2016)

Bufalin Suppresses Migration and Invasion of Hepatocellular Carcinoma Cells Elicited by Poly (I:C) Therapy
por: Feng, Yinglu, et al.
Publicado: (2018)

Poly(I:C) Enhances the Susceptibility of Leukemic Cells to NK Cell Cytotoxicity and Phagocytosis by DC
por: Lion, Eva, et al.
Publicado: (2011)

Immunotherapeutic effects of intratumoral nanoplexed poly I:C
por: Aznar, M. Angela, et al.
Publicado: (2019)

Intravenous albumin for the prevention of hemodynamic instability during sustained low-efficiency dialysis: a randomized controlled feasibility trial (The SAFER-SLED Study)
por: Clark, Edward G., et al.
Publicado: (2021)

Effect of blood donor characteristics on transfusion outcomes: a protocol for systematic review and meta-analysis
por: Chassé, Michaël, et al.
Publicado: (2014)

Comparison of freshly cultured versus freshly thawed (cryopreserved) mesenchymal stem cells in preclinical in vivo models of inflammation: a protocol for a preclinical systematic review and meta-analysis
por: Dave, Chintan, et al.
Publicado: (2020)

Efficacy and safety of mesenchymal stromal cells in preclinical models of acute lung injury: a systematic review protocol
por: Lalu, Manoj M, et al.
Publicado: (2014)

The Response of Tissue Mast Cells to TLR3 Ligand Poly(I:C) Treatment
por: Witczak, Piotr, et al.
Publicado: (2020)

poly(I:C) synergizes with proteasome inhibitors to induce apoptosis in cervical cancer cells
por: Meng, Xueqiong, et al.
Publicado: (2022)

In vitro effects of monophosphoryl lipid A and Poly I:C combination on equine cells
por: Lee, Dong-Ha, et al.
Publicado: (2023)

Subarachnoid hemorrhage admissions retrospectively identified using a prediction model
por: English, Shane W., et al.
Publicado: (2016)

Poly(I:C) Potentiates T Cell Immunity to a Dendritic Cell Targeted HIV-Multiepitope Vaccine
por: Apostólico, Juliana de Souza, et al.
Publicado: (2019)

Combination immunotherapy of glioblastoma with dendritic cell cancer vaccines, anti-PD-1 and poly I:C
por: Zhu, Ping, et al.
Publicado: (2023)

Efficacy and safety of regenerative cell therapy for pulmonary arterial hypertension in animal models: a preclinical systematic review protocol
por: Suen, Colin M., et al.
Publicado: (2016)

Antiviral responses of human Leydig cells to mumps virus infection or poly I:C stimulation
por: Le Tortorec, A., et al.
Publicado: (2008)

Proteomic analysis of Pteropus alecto kidney cells in response to the viral mimic, Poly I:C
por: Mok, Lawrence, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_9i8uph2sd6ekvm3vndc8stn4iu